Paul Tudor Jones's GPCR Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 75,301 shares of Structure Therapeutics Inc. (GPCR) worth $3.63 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in GPCR, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 40,248 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Structure Therapeutics (GPCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Structure Therapeutics (GPCR) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +40,248 | Add 114.82% | 75,301 | $48.20 |
| Q4 2025 | +35,053 | New Buy | 35,053 | $69.55 |
Paul Tudor Jones's Structure Therapeutics Investment FAQs
Paul Tudor Jones first purchased Structure Therapeutics Inc. (GPCR) in Q4 2025, acquiring 35,053 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Structure Therapeutics Inc. (GPCR) for 2 quarters since Q4 2025.
Paul Tudor Jones's largest addition to Structure Therapeutics Inc. (GPCR) was in Q1 2026, adding 75,301 shares worth $3.63 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 75,301 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $3.63 M.
As of the Q1 2026 filing, Structure Therapeutics Inc. (GPCR) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Structure Therapeutics Inc. (GPCR) was 75,301 shares, as reported at the end of Q1 2026.